Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 25Neoplasms 12Stomach Neoplasms 10Endometrial Neoplasms 10Lung Neoplasms 9Lymphatic Metastasis 7Melanoma 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Esophageal Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Vulvar Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Ovarian Neoplasms 3Colorectal Neoplasms 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skull Base Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Peritoneal Neoplasms 2Osteosarcoma 2Margins of Excision 2Lymphedema 2Hypoparathyroidism 2Giant Cell Tumor of Bone 2

Interventions

Radiotherapy 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Indocyanine Green 1Ifosfamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mixed Tumor, Mesodermal × Indocyanine Green × Clear all
NCT01737619 2026-05-04

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
101 enrolled 8 charts

Mixed Tumor, Mesodermal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡